Skip to content

US FDA approves Pfizer's nasal spray for migraine

The US Food and Drug Administration (FDA) has approved Pfizer Inc's Zavzpret nasal spray for migraine treatment. Zavzpret is expected to launch in July 2021. It is comparable in price to other FDA-approved migraine medicines.

  • US FDA approves Pfizer's nasal spray for migraine.
  • The drug, Zavzpret, was approved for the treatment of acute migraine.
  • Zavzpret is expected to launch in July and is comparable in price to other FDA-approved migraine medicines.
US FDA approves Pfizer's nasal spray for migraine
The U.S. Food and Drug Administration on Friday approved Pfizer Inc's nasal spray for migraine, giving patients access to a potentially fast-acting pain-relief option for headaches.

Latest